🇺🇸 Hydromorphone PCA in United States

17 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Mental Status Changes — 3 reports (17.65%)
  2. Disease Progression — 2 reports (11.76%)
  3. Drug Ineffective — 2 reports (11.76%)
  4. Dyspnoea — 2 reports (11.76%)
  5. Hospice Care — 2 reports (11.76%)
  6. Oxygen Saturation Decreased — 2 reports (11.76%)
  7. Abdominal Pain — 1 report (5.88%)
  8. Apnoea — 1 report (5.88%)
  9. Ataxia — 1 report (5.88%)
  10. Back Pain — 1 report (5.88%)

Source database →

Hydromorphone PCA in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Hydromorphone PCA approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Hydromorphone PCA in United States?

M.D. Anderson Cancer Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.